Welcome to our dedicated page for American Fusion news (Ticker: AMFN), a resource for investors and traders seeking the latest updates and insights on American Fusion stock.
American Fusion Inc. reports company developments tied to its Texatron fusion energy platform, including pre-production assembly readiness, component integration, diagnostic and testing support, and related working-capital needs. News also covers corporate actions involving the company's authorized-share structure, common-share base, financing arrangements, governance updates, and operating results.
American Fusion news also includes activity from its Government Procurement Services segment, which is positioned separately from the company's core fusion development activities. That coverage centers on government and institutional procurement work, source-of-supply vendor activity, and the company's broader public-company transition under the AMFN symbol.
American Fusion (OTC: AMFN) filed six additional U.S. patent applications for its Texatron™ Fusion Engine™, bringing its total U.S. patent filings to 82. The new applications cover various rifled toroidal fusion confinement devices and system architectures, reinforcing the company’s strategy to protect core reactor, control, and power-management innovations.
American Fusion has responded to what it believes is the final comment round on its Form 211, the last regulatory step before potential eligibility for quotation on the OTCQB Market, subject to OTC requirements. The company is also preparing the next testing phase of the Texatron™ program at Texas Tech University, focusing on subsystem verification, control and ignition systems, fuel delivery, plasma and magnetic control, and further calibration of test equipment.
American Fusion (OTC: AMFN) has appointed Texas Tech physicist Dr. Noah D’Amico as Strategic Advisor to support the next phase of Texatron™ Fusion Engine™ testing at Texas Tech University.
Dr. D’Amico, a 2026 Ph.D. graduate and Lead Engineer in Texas Tech’s Department of Physics & Astronomy and COO of BlankSlate Innovation, brings expertise in nuclear diagnostics, neutron detection, radiation measurements, vacuum systems, AI-assisted particle-track analysis, and advanced nuclear instrumentation. He will advise on laboratory preparation, experimental planning, radiation diagnostics, instrumentation, data collection, and documentation as American Fusion begins initial Texatron™ testing activities at Texas Tech, subject to laboratory scheduling and operational readiness.
American Fusion (OTC: AMFN) reported completion of the initial phase of engineering and testing for its Texatron™ Fusion Engine™ at Texas Tech University’s Center for Emerging Energy Sciences in Lubbock, Texas. A seven-member company team, working with Texas Tech personnel, conducted subsystem demonstrations, instrumentation testing, and laboratory evaluations.
According to American Fusion, the phase achieved key objectives, including successful operation of the remote ignition and control system, plasma switching with non-radioactive fusion fuel, and high-voltage operation in a controlled vacuum. Radiation monitoring and diagnostics were evaluated and calibrated, with no measurable radiation detected. The company also designed, built, and tested a specialized high-voltage power supply integrated with the Texatron™ platform. Data from this phase will guide multiple subsequent testing phases, with American Fusion planning further technical updates, a published technical summary, and a short video for shareholders.
American Fusion (OTC: AMFN) has begun its planned Texatron™ Fusion Engine™ testing program at Texas Tech University after completing initial laboratory preparations and successfully verifying its remote ignition system. Seven team members prepared the physics and astronomy research facilities, checked instrumentation and interfaces, and evaluated the Texatron™ platform’s operational readiness.
The verified remote ignition system is designed to enable precise, repeatable and safe plasma pulse initiation from a remote location. According to American Fusion, testing is expected to continue through the week with further subsystem verification, calibration, diagnostics and experimental evaluations, with technical data to be released only after internal review and validation.
American Fusion (OTC: AMFN) reported that CTO Dr. John E. Brandenburg presented the Texatron™ Fusion Engine™ development program and his Gravity-Electromagnetic (GEM) Unification Theory at the APS Division of Particles and Fields 2026 Meeting at Fermilab, held July 20‑24, 2026.
According to American Fusion, the GEM framework proposes a first-principles mathematical derivation of Newton’s gravitational constant G from early-universe hydrogen plasma conditions, explicitly incorporates quantum mechanics via the fine-structure constant, and yields a parameter linked to the proton‑electron mass ratio. The company believes these plasma-physics concepts may inform future theoretical work supporting Texatron™. Management highlighted strong audience engagement and noted plans to file the Q2 2026 Form 10‑Q by the deadline and to release an interview with the Executive Chairman on recent progress and commercialization strategy.
American Fusion (OTC: AMFN) highlighted recent operational, regulatory and commercialization developments discussed by Executive Chairman Brent Nelson in an interview with SmallCapVoice.com. The company recently received Texas Department of State Health Services certification covering all twelve registered Texatron™ Fusion Engine™ models, from 500 kilowatts to gigawatt scale, clearing the way for a testing program.
Initial testing at Texas Tech University is expected to validate fusion reactions, measure plasma parameters, evaluate pulse-generated electrical output and advance toward sustained electricity generation, with data documented independently. American Fusion is targeting data centers, industrial users, mining, defense and space applications, has appointed a Chief Revenue Officer, is expanding its patent portfolio, launched an AI-powered investor communications platform, and aims in 2026 to advance testing, pursue initial power placement agreements and begin planning for a 100-megawatt unit.
American Fusion (OTC: AMFN) filed nineteen additional U.S. patent applications covering multiple elements of its Texatron™ Fusion Engine™ platform, including reactor architecture, plasma confinement, electromagnetic systems, fuel delivery, control, and power management. This brings total U.S. patent applications to 76, toward a stated objective of filing more than 260 Texatron-related applications.
The company reports that its engineering and operations team has departed for Texas Tech University to install and calibrate electronics, vacuum, switching, imaging, and data systems ahead of next week’s planned testing program. Separately, Dr. John E. Brandenburg is scheduled to present Texatron™ at a Fermilab scientific conference, supporting broader technical engagement.
American Fusion (OTC: AMFN) has appointed Alec Rossa as Chief Revenue Officer to lead global commercial strategy for its Texatron™ Fusion Engine™ platform and planned Power-as-a-Service (PaaS) model. Rossa will oversee customer development, strategic partnerships, and government and institutional relationships.
Rossa previously served nearly 20 years as President and CEO of MD Charlton, which expanded from a regional supplier into a nationwide distributor for military, law enforcement and first responder agencies in Canada. According to American Fusion, his experience with complex procurement, sophisticated commercial agreements and public safety, defense and national security markets is expected to support commercialization planning, strategic alliances and long-term deployment opportunities for the Texatron™ platform.
American Fusion (OTC: AMFN) has received Texas Department of State Health Services Certificate of Registration No. R54726 for its Texatron™ Fusion Engine™ industrial radiation machines. Issued on July 17, 2026 and effective through February 28, 2034, the registration identifies American Fusion as registrant, names Dr. John E. Brandenburg as Radiation Safety Officer, and covers 12 Texatron™ research model classes from 500 kW to 1 GW for research use at an authorized facility in Lubbock, Texas.
According to American Fusion, under an agreement with BlankSlate Innovation (BSI), testing will occur at specialized radiation-testing facilities coordinated with Texas Tech University, with research and development testing of the 500 kW and 5 MW Texatron™ systems expected to begin the week of July 27, 2026, subject to scheduling. The certificate authorizes specified R&D activities, including progressive machine testing and technical validation, but does not certify commercial performance or confirm that any model has achieved its rated net electrical output or commercial readiness.
American Fusion (OTC: AMFN) announced that the Texas Department of State Health Services has issued a Certificate of Registration for Industrial Radiation Machines on July 17, 2026. The certificate authorizes research and development activities using the company’s registered Texatron™ Fusion Engine™ systems at its approved testing site at Texas Tech University in Lubbock, Texas.
The registration, effective through February 28, 2034, allows American Fusion to receive, possess, acquire, transfer, and use industrial radiation machines for R&D under Texas radiation control regulations and the company’s radiation safety program. It designates Dr. John E. Brandenburg as Radiation Safety Officer and covers twelve Texatron™ research systems ranging from 500 kW to 1 GW, including the planned 5 MW Texatron™ Fusion Engine™ testing. According to the company, no other known material permits or approvals are required for this testing program.